Polomar Health Services, Inc. (PMHS) stock
PMHSOTCPharmaceutical PreparationsFiscal year ends December 31
$0.12−0.01 (-4.00%)
Close on Oct 19, 2026Market cap $3.37MP/E –Yield –
Polomar Health Services r&d expenses
Research and development expenses are spending on new products and technology.
No r&d expenses figures for Polomar Health Services
Polomar Health Services has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?